Mettler-Toledo International, I
MTD Large CapHealthcare · Diagnostics & Research
Mis à jour: Jun 18, 2026, 22:21 UTC
Price Chart
Indicateurs clés
Valuation Analysis
About the Company
Mettler-Toledo International, I en bref
Mettler-Toledo International, I (MTD) is currently trading at 996,56 € with a market capitalization of 20,1 Md €. The trailing P/E ratio stands at 26.83x, with a forward P/E of 22.29x. The 52-week range spans from 891,86 € to 1 329,59 €; the current price is 25% below the yearly high. Year-over-year revenue growth stands at +7.2%. The net profit margin stands at 21.4%.
💰 Dividende
Mettler-Toledo International, I currently does not pay a dividend. The company typically reinvests its earnings into growth initiatives and product development.
📊 Avis des analystes
12 analystes évaluent Mettler-Toledo International, I (MTD) au consensus : Acheter. L'objectif de cours moyen est de 1 157,55 €, soit un potentiel de +16.16% par rapport au cours actuel. La fourchette des objectifs de cours des analystes va de 1 040,89 € à 1 351,23 €.
Mettler-Toledo International, I : la thèse d'investissement en détail
Mettler-Toledo International, I (MTD) operates in the Healthcare — specifically Diagnostics & Research — and is headquartered in Switzerland. Below is a structured read of the investment case built directly from the latest fundamentals, valuation multiples, analyst positioning and smart-money flows. Each section translates raw numbers into the investment logic they imply, so you can decide whether the risk/reward fits your portfolio.
Le scénario haussier
The combination of a 59.19% gross margin and 23.29% operating margin shows the business converts revenue into profit efficiently — a hallmark of competitive moat. Free cash flow is positive and net margins stand at 21.4%, meaning reported earnings translate into real cash that can fund buybacks, dividends or strategic acquisitions. Wall Street consensus sits at Buy with an average price target implying roughly 16.16% upside from current levels — analyst sentiment is firmly constructive.
À surveiller
- The forward P/E of 22.29x is meaningfully below the trailing 26.83x — analysts expect earnings to step up; the next earnings release is the test.
- The price sits in the lower quartile of the 52-week range — value hunters often start scaling in around this zone if fundamentals hold.
Thèse d'investissement : forces et faiblesses
- Rentable avec une marge nette de 21.4%
- Marge brute élevée de 59.19% — signe d'un pouvoir de fixation des prix
- Consensus des analystes : Buy
- Free cash flow positif
Aucun signal d'alerte significatif dans les indicateurs actuels.
Aperçu technique
Price is below both the 50- and 200-day moving averages, with 50d below 200d — a bearish picture (death-cross alignment).
Profil de risque
The data points to market-like volatility.
Trading Data
Related Stocks in the Same Sector
More Santé stocks
Top peers in the same sector — ranked by market cap.
Where can I buy Mettler-Toledo International, I?
Compare top-rated brokers — low fees, trusted providers, fully regulated.
Live Market Data
Real-time chart, financials, earnings, analysts, insider trades, events & news
